Preprint · CC-BY
via OpenAlex
Non‐hematopoietic human bone marrow contains long‐lasting, pluripotential mesenchymal stem cells
Domizio Suvà, Guido Garavaglia, Jacques Ménétrey, B Chapuis, Pierre J Hoffmeyer, Laurent Bernheim, Vincent Kindler
Journal of Cellular Physiology · 2003 · ▲ 119 citations
Abstract
Mesenchymal stem cells (MSC) are considered as potential agents for reconstructive and gene-targeting therapies since they differentiate into various cell-lineages, exhibit an extended survival once injected into a host, and can easily be transfected with engineered DNA. MSC are essentially isolated from hematopoietic bone marrow (BM), a process that is rather invasive and may raise ethical concerns. In an attempt to find an alternative source, we evaluated whether non-hematopoietic (nh)BM recovered from femoral heads of patients undergoing hip arthroplasty contained MSC. Ex vivo, 99% of nhBM cells were CD45(+) leukocytes. After culture, leukocytes were replaced by a homogeneous layer of adherent CD45(-) CD14(-) CD34(-) CD11b(-) CD90(+) HLA-ABC(+) cells. Culture doubling time (mean = 4 days, range 1.6-6.7 days) was not correlated with patient age (27-81 years, n = 16). Amplified cultures supported long-term hematopoiesis, and could be differentiated in vitro into adipocytes and chondrocytes. Moreover, a small fraction of nhBM cells spontaneously expressed MyoD1 and formed myotubes, suggesting that myogenic differentiation also occurred. nhBM contained clonogenic cells whose frequency (1/13,000), doubling time (2.1 days), and maximal amplification (up to 10(6)-fold) were not age-related. All 14 clones analyzed (from five patients, ages 27-78 years) differentiated into at least one mesenchymal lineage, and 66% were bipotential (n = 8/12), or tripotential (n = 2/3). In conclusion, nhBM contains pluripotential mesenchymal progenitors which are similar to hematopoietic BM-derived MSC, and whose biological functions are not altered by aging. Furthermore, if MSC-based therapies hold their promises, nhBM may become the source of choice for responding to the increasing demand for MSC.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/jcp.10396
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Suvà, D., Garavaglia, G., Ménétrey, J., Chapuis, B., Hoffmeyer, P.J., Bernheim, L., & Kindler, V. (2003). Non‐hematopoietic human bone marrow contains long‐lasting, pluripotential mesenchymal stem cells. <em>Journal of Cellular Physiology</em>. https://doi.org/10.1002/jcp.10396
Vancouver
Suvà D, Garavaglia G, Ménétrey J, Chapuis B, Hoffmeyer PJ, Bernheim L, et al. Non‐hematopoietic human bone marrow contains long‐lasting, pluripotential mesenchymal stem cells. Journal of Cellular Physiology. 2003. doi:10.1002/jcp.10396.
BibTeX
@unpublished{domizio2003Nonhem,
title = {Non‐hematopoietic human bone marrow contains long‐lasting, pluripotential mesenchymal stem cells},
author = {Domizio Suvà and Guido Garavaglia and Jacques Ménétrey and B Chapuis and Pierre J Hoffmeyer and Laurent Bernheim and Vincent Kindler},
journal = {Journal of Cellular Physiology},
year = {2003},
doi = {10.1002/jcp.10396},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Orthopaedic Research® 2002
Citation only
Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats
PLoS ONE 2011
Open access · CC-BY
Reduced Reactivation from Dormancy but Maintained Lineage Choice of Human Mesenchymal Stem Cells with Donor Age
Stem Cells International 2022
Open access · CC-BY
Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting
Stem Cell Research & Therapy 2015
Open access · CC-BY
Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells
Expert Opinion on Biological Therapy 2023
Preprint · OA
Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells
BMC Genomics 2007
Open access · CC-BY